Vincent mangematin
Vincent mangematin
Adresse e-mail validée de kedgebs.com
TitreCitée parAnnée
Business models: A challenging agenda
C Baden-Fuller, V Mangematin
Strategic Organization 11 (4), 418-427, 2013
3232013
PhD job market: professional trajectories and incentives during the PhD
V Mangematin
Research policy 29 (6), 741-756, 2000
2752000
What kind of knowledge can a firm absorb?
V Mangematin, L Nesta
International Journal of Technology Management 18 (3-4), 149-172, 1999
2611999
From recipe to dinner: business model portfolios in the European biopharmaceutical industry
V Sabatier, V Mangematin, T Rousselle
Long Range Planning 43 (2-3), 431-447, 2010
2442010
Development of SMEs and heterogeneity of trajectories: the case of biotechnology in France
V Mangematin, S Lemarié, JP Boissin, D Catherine, F Corolleur, ...
Research Policy 32 (4), 621-638, 2003
2422003
Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry
J Zhang, C Baden-Fuller, V Mangematin
Research policy 36 (4), 515-528, 2007
2292007
Technological agglomeration and the emergence of clusters and networks in nanotechnology
DKR Robinson, A Rip, V Mangematin
Research policy 36 (6), 871-879, 2007
2192007
Profile of public laboratories, industrial partnerships and organisation of R & D: the dynamics of industrial relationships in a large research organisation
PB Joly, V Mangematin
Research policy 25 (6), 901-922, 1996
1791996
Collaboration, creativity and rewards: why and how scientists collaborate
G Laudel
International Journal of Technology Management 22 (7-8), 762-781, 2001
1662001
Is the creation and development of biotech SMEs localised? Conclusions drawn from the French case
S Lemarié, V Mangematin, A Torre
Small Business Economics 17 (1-2), 61-76, 2001
1322001
Understanding the emergence and deployment of “nano” S&T
B Bozeman, P Larédo, V Mangematin
Research Policy 36 (6), 807-812, 2007
1302007
Turning scientific and technological human capital into economic capital: the experience of biotech start-ups in France
CDF Corolleur, M Carrere, V Mangematin
Research Policy 33 (4), 631-642, 2004
1212004
When technological discontinuities and disruptive business models challenge dominant industry logics: Insights from the drugs industry
V Sabatier, A Craig-Kennard, V Mangematin
Technological Forecasting and Social Change 79 (5), 949-962, 2012
1172012
University technology transfer offices: The search for identity to build legitimacy
C O’kane, V Mangematin, W Geoghegan, C Fitzgerald
Research Policy 44 (2), 421-437, 2015
942015
Editor's introduction: Scientific and technical human capital
B Bozeman, V Mangematin
Research Policy 33 (4), 565-568, 2004
922004
Orchestrating innovation with user communities in the creative industries
G Parmentier, V Mangematin
Technological forecasting and social change 83, 40-53, 2014
912014
Profiles of academic activities and careers: Does gender matter? An analysis based on French life scientist CVs
M Sabatier, M Carrere, V Mangematin
The Journal of Technology Transfer 31 (3), 311-324, 2006
882006
The future of nanotechnologies
V Mangematin, S Walsh
Technovation 32 (3-4), 157-160, 2012
852012
Diversification and hybridization in firm knowledge bases in nanotechnologies
E Avenel, AV Favier, S Ma, V Mangematin, C Rieu
Research Policy 36 (6), 864-870, 2007
802007
La confiance: un mode de coordination dont l'utilisation dépend de ses conditions de production
V Mangematin
Confiance et entreprise, 21 p., 1997
801997
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20